Entity Common Stock, Shares Outstanding of NUTRA PHARMA CORP from 08 Aug 2011 to 11 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NUTRA PHARMA CORP quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 08 Aug 2011 to 11 Mar 2026.
  • NUTRA PHARMA CORP Entity Common Stock, Shares Outstanding for the quarter ending 11 Mar 2026 was 7,159,727,214.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NUTRA PHARMA CORP Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 7,159,727,214 11 Mar 2026 10-Q 11 Mar 2026 2025 Q1
Q1 2026 7,159,727,214 17 Feb 2026 10-K 17 Feb 2026 2024 FY
Q4 2025 7,099,727,214 02 Jan 2026 10-Q 02 Jan 2026 2024 Q3
Q4 2025 7,099,727,214 24 Nov 2025 10-K 24 Nov 2025 2023 FY
Q3 2025 7,099,727,214 16 Oct 2025 10-Q 16 Oct 2025 2023 Q1
Q4 2022 7,596,852,214 21 Nov 2022 10-Q 21 Nov 2022 2022 Q3
Q3 2022 7,586,352,214 +308,732,500 +4.2% 22 Aug 2022 10-Q 22 Aug 2022 2022 Q2
Q2 2022 7,363,852,214 +103,732,500 +1.4% 20 May 2022 10-Q 20 May 2022 2022 Q1
Q1 2022 7,363,852,214 +508,655,000 +7.4% 15 Apr 2022 10-K 15 Apr 2022 2021 FY
Q3 2021 7,277,619,714 24 Sep 2021 10-Q 24 Sep 2021 2021 Q2
Q2 2021 7,260,119,714 01 Jul 2021 10-K 01 Jul 2021 2019 FY
Q1 2021 6,855,197,214 05 Apr 2021 10-Q 05 Apr 2021 2019 Q1
Q4 2020 6,855,197,214 05 Feb 2021 10-K 05 Feb 2021 2018 FY
Q4 2018 4,020,246,110 +2,156,828,542 +116% 19 Nov 2018 10-Q 19 Nov 2018 2018 Q3
Q2 2018 2,332,105,170 21 May 2018 10-Q 21 May 2018 2018 Q1
Q1 2018 2,261,233,701 +1,878,863,544 +491% 16 Apr 2018 10-K 17 Apr 2018 2017 FY
Q4 2017 1,863,417,568 +1,568,352,251 +532% 20 Nov 2017 10-Q 20 Nov 2017 2017 Q3
Q3 2017 1,084,952,924 +894,505,703 +470% 15 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 382,370,157 +275,475,577 +258% 15 May 2017 10-Q 17 May 2017 2017 Q1
Q4 2016 295,065,317 +218,673,727 +286% 31 Dec 2016 10-K 17 Apr 2017 2016 FY
Q3 2016 190,447,221 +125,399,467 +193% 19 Aug 2016 10-Q 22 Aug 2016 2016 Q2
Q2 2016 106,894,580 +67,155,858 +169% 26 May 2016 10-Q 21 Jun 2016 2016 Q1
Q1 2016 106,894,580 -1,405,055,741 -93% 13 Apr 2016 10-K 14 Apr 2016 2015 FY
Q4 2015 76,391,590 20 Nov 2015 10-Q 23 Nov 2015 2015 Q3
Q3 2015 65,047,754 -1,335,859,358 -95% 17 Aug 2015 10-Q 18 Aug 2015 2015 Q2
Q2 2015 39,738,722 -1,086,384,392 -96% 19 May 2015 10-Q 19 May 2015 2015 Q1
Q1 2015 1,511,950,321 +455,676,264 +43% 13 Apr 2015 10-K 13 Apr 2015 2014 FY
Q3 2014 1,400,907,112 +682,765,399 +95% 14 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 1,126,123,114 20 May 2014 10-Q 20 May 2014 2014 Q1
Q1 2014 1,056,274,057 +466,880,798 +79% 31 Mar 2014 10-K 31 Mar 2014 2013 FY
Q4 2013 951,073,019 +428,938,343 +82% 19 Nov 2013 10-Q 19 Nov 2013 2013 Q3
Q3 2013 718,141,713 +196,007,037 +38% 15 Aug 2013 10-Q 19 Aug 2013 2013 Q2
Q1 2013 589,393,259 15 Apr 2013 10-K 16 Apr 2013 2012 FY
Q4 2012 522,134,676 26 Nov 2012 10-Q/A 12 Dec 2012 2012 Q3
Q3 2012 522,134,676 +206,821,003 +66% 09 Nov 2012 10-Q/A 28 Nov 2012 2012 Q1
Q3 2011 315,313,673 09 Nov 2011 10-Q 15 Nov 2011 2011 Q3
Q2 2011 301,795,618 08 Aug 2011 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.